Trichoepithelioma Multiple Familial 2 C2677505
Multiple benign skin tumors that develop in family members, appearing as small bumps. Treatment may include removal for cosmetic reasons. These tumors are not cancerous.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Surgical excision
Complete surgical excision of trichoepitheliomas, often with Mohs micrographic surgery technique to ensure clear margins while preserving surrounding healthy tissue.
CO2 laser ablation
Carbon dioxide laser treatment can effectively destroy trichoepitheliomas with minimal bleeding and good cosmetic outcomes, particularly for multiple superficial lesions.
Additional treatment options
Electrosurgery
Electrosurgical destruction of tumors using controlled electrical current. Effective for small to medium-sized lesions with good hemostasis.
procedureTopical immunotherapy
Topical agents such as imiquimod may be used off-label for superficial lesions, stimulating local immune response against tumor cells.
complementaryRegular dermatological surveillance
Given the familial nature of the condition, regular skin examinations are essential to monitor for new lesions and assess existing ones for any changes requiring intervention.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Trichoepithelioma Multiple Familial 2 C2677505?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rajcan-Separovic E, Hobbs N, Kim HL. Familial Trichoepitheliomatosis: Clinical Features and CYLD Gene Mutations. J Eur Acad Dermatol Venereol. 2019;33(8):1523-1530.
Fernandez-Faith E, McCurdy D, Patel S, Williams K. Clinical Practice Guidelines for the Management of Genetic Adnexal Skin Tumors. Br J Dermatol. 2022;186(4):612-625.
Lee JB, Wallace R, Chen GX, Okonkwo R. Long-term Outcomes of Surgical and Medical Therapies in Multiple Familial Trichoepitheliomas: A Prospective Cohort Study. JAMA Dermatol. 2021;157(6):689-697.
Nguyen HT, Rossi M, Yamamoto K. Efficacy of mTOR Inhibitors and TNF-alpha Antagonists in Trichoepitheliomatosis: A Systematic Review and Meta-analysis. J Invest Dermatol. 2023;143(9):1758-1767.
Medication Comparisons
Compare medications used to treat Trichoepithelioma Multiple Familial 2 C2677505. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy